thalidomide has been researched along with Chronic Hepatitis B in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of acute fatal exacerbation of chronic hepatitis B in a 50-year-old man with multiple myeloma being treated with thalidomide." | 7.72 | Acute exacerbation of chronic hepatitis B during thalidomide therapy for multiple myeloma: a case report. ( Ahn, JY; Bang, SM; Cho, EK; Kim, SS; Lee, JH; Park, SH; Shin, DB, 2004) |
| "We report a case of acute fatal exacerbation of chronic hepatitis B in a 50-year-old man with multiple myeloma being treated with thalidomide." | 3.72 | Acute exacerbation of chronic hepatitis B during thalidomide therapy for multiple myeloma: a case report. ( Ahn, JY; Bang, SM; Cho, EK; Kim, SS; Lee, JH; Park, SH; Shin, DB, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, P | 1 |
| Bang, SM | 1 |
| Kim, SS | 1 |
| Park, SH | 1 |
| Ahn, JY | 1 |
| Cho, EK | 1 |
| Shin, DB | 1 |
| Lee, JH | 1 |
1 review available for thalidomide and Chronic Hepatitis B
| Article | Year |
|---|---|
Lenalidomide-induced acute liver failure.
Topics: Adenine; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Hepatitis B, Chronic; Humans; L | 2009 |
1 other study available for thalidomide and Chronic Hepatitis B
| Article | Year |
|---|---|
Acute exacerbation of chronic hepatitis B during thalidomide therapy for multiple myeloma: a case report.
Topics: Angiogenesis Inhibitors; Hepatitis B, Chronic; Humans; Klebsiella Infections; Male; Middle Aged; Mul | 2004 |